Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Humacyte (HUMA) Interest & Investment Income (2024 - 2025)

Humacyte has reported Interest & Investment Income over the past 2 years, most recently at $503000.0 for Q4 2025.

  • Quarterly results put Interest & Investment Income at $503000.0 for Q4 2025, down 40.96% from a year ago — trailing twelve months through Dec 2025 was $2.6 million (down 36.96% YoY), and the annual figure for FY2025 was $2.6 million, down 36.96%.
  • Interest & Investment Income for Q4 2025 was $503000.0 at Humacyte, down from $590000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for HUMA hit a ceiling of $1.3 million in Q2 2024 and a floor of $503000.0 in Q4 2025.